STEPHANIE GORT: Open Payments
NPI 1043610462 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,864 in 105 payments from 16 companies in 2025. Trend: 2023 $866 · 2024 $1,432 · 2025 $15,864
Speaker / faculty: $10,415Food & beverage: $2,885Travel & lodging: $1,349Consulting: $1,215
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $11,788 |
| Madrigal Pharmaceuticals | 16 | $2,417 |
| ABBVIE INC. | 19 | $430 |
| Ardelyx, Inc. | 14 | $257 |
| Lilly USA, LLC | 9 | $169 |
| Phathom Pharmaceuticals, Inc. | 3 | $163 |
| Gilead Sciences, Inc. | 2 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| Celltrion USA Inc. | 4 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
Products named: Wegovy, REZDIFFRA, IBSRELA, VOQUEZNA, Livdelzi, SKYRIZI, OMVOH, GATTEX.
Industry payments across CT — which companies pay providers there.
